Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China
· Delayed Price · Currency is CNY 30.80
+0.01 (0.03%)
At close: Apr 29, 2026
Chongqing Genrix Biopharmaceutical Employees
Chongqing Genrix Biopharmaceutical had 793 employees as of June 30, 2025. The number of employees increased by 50 or 6.73% since the number was reported on December 31, 2024.
Employees
793
Change
50
Growth
6.73%
Revenue / Employee
310.53K CNY
Profits / Employee
-721.70K CNY
Market Cap
11.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 793 | 50 | 6.73% |
| Dec 31, 2024 | 743 | 196 | 35.83% |
| Dec 31, 2023 | 547 | 155 | 39.54% |
| Dec 31, 2022 | 392 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 463 |
| Hualan Biological Vaccine | 708 |
| Pacific Shuanglin Bio-pharmacy | 2,635 |
| Chengdu Easton Biopharmaceuticals | 1,522 |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 9,293 |
| Vcanbio Cell & Gene Engineering Corp., | 2,014 |
| HitGen | 492 |
| InventisBio | 168 |